BioValues

24.6K posts

BioValues

BioValues

@BioValues

Biotech investor. Tend to focus on contrarian names, so I'm probably buying what you are selling/hating on. All tweets are my opinions only.

Denver Katılım Haziran 2010
316 Takip Edilen9.3K Takipçiler
BioValues
BioValues@BioValues·
$OKUR would be wise to capitalize on this and announce data and their own pan mutant plans Monday AM
English
0
0
2
469
BioValues
BioValues@BioValues·
small rally, any news?
English
4
0
5
1.9K
BioValues
BioValues@BioValues·
$OKUR nice move today in an ugly tape
English
2
0
1
782
BioValues
BioValues@BioValues·
$ARTV surprised stock is being hit so hard the past few days after these very bullish abstract titles came out. Should be running up IMO. Many positive hints (including the hires) that they are likely seeing good data in RA, etc. Cantor calling this a "very meaningful catalyst"
BioValues tweet media
English
0
0
0
418
BioValues
BioValues@BioValues·
$ARTV HUGE hints just posted today on EULAR online program. Three presentations listed for early June. "Robust and durable clinical responses...in severe RA" and "highly effective in severe Sjogren Disease" (company hinted this is next indication). Exciting couple months ahead!
BioValues tweet media
English
8
0
14
2.3K
BioValues
BioValues@BioValues·
@B_C_1776 considering I see shitco without arry's C team moon all the time on data, I'll take my chances on this one.
English
0
0
0
103
BioValues
BioValues@BioValues·
$OKUR certainly trading like really good news coming. Up 7% in an ugly tape
English
0
0
3
1.1K
BioValues
BioValues@BioValues·
$okur nice continued strength into data
English
0
0
3
985
BioValues
BioValues@BioValues·
$ACET I don't see any presentations listed for EULAR, so looks like they will issue a standalone press release on their LN, SLE and SSc data update, like they did in early Oct. April seems logical, as it will be 6 months post the initial data: investor.adicetbio.com/news-releases/…
English
0
0
4
936
BioValues
BioValues@BioValues·
@Jn66039675 just about the high bar of showing greater or equal to ACR 50 in 50% or more patients, and moving into pivotal RA trial, expansion into additional indications, etc.
English
0
0
1
54
BioValues
BioValues@BioValues·
@Jn66039675 indeed. And when you couple that with the statements from CEO and all the hiring, and additions of big names lately.
English
1
0
0
55
Peter T
Peter T@Jn66039675·
@BioValues the titles of the abstracts are quite telling
English
1
0
0
47
Peter T
Peter T@Jn66039675·
@BioValues Do you know when the abstracts are published?
English
1
0
0
108
mar
mar@BioLobotomy·
@BioValues Yo! What a catch. Can you give me the exact link? I'd like to check when these were indexed, to see if this is already priced in.
English
2
0
0
149
BioValues
BioValues@BioValues·
What's weighing on $XBI this time? 🙄
English
1
0
1
971
BioValues
BioValues@BioValues·
$OKUR heavy volume and seeing some 50k blocks go in
English
0
0
4
1.3K
BioValues
BioValues@BioValues·
$OKUR over $4, I imagine data is next week
English
0
0
6
1.2K
M.Á
M.Á@rezfszubagoly·
@BioValues What do you think the bar is for the triplet? Mono seems to be a zero considering that they want to "contextualize" the data, but they indeed seem confident generally
English
1
0
0
61
BioValues
BioValues@BioValues·
$OKUR wow, they presented last Wed at Oppenheimer and never PRed it. They have a webcast up and so far it's quite bullish "very robust data set coming...of our accomplishments" "presumably transitioning into a pivotal studies in not too distant future"
BioValues tweet media
English
3
1
5
2.3K